Ryo Hatano

Juntendo University Graduate School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Tsutomu Sato

University of Toyama

JAPAN

View details

Yusuke Kamihara

Assistant Professor

University of Toyama

JAPAN

View details

Kotaro Honda

Juntendo University

JAPAN

View details

Takeshi Kawasaki

Assistant professor

Chiba University

JAPAN

View details

Daniele Corridoni

University of Oxford

UNITED KINGDOM

View details

Hashem Koohy

University of Oxford

UNITED KINGDOM

View details

Hiroyuki Kishi

University of Toyama

JAPAN

View details

Akinori Wada

University of Toyama

JAPAN

View details

Yuji Kamikubo

Associate Professor

Juntendo University

JAPAN

View details

Yoshihiro Hayakawa

Professor

JAPAN

View details

Yoshitoshi Kasuya

Associate Professor

Chiba University

JAPAN

View details

David Fawkner-Corbett

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ryo Hatano

Research Interests

Explore related searches

Contact this professor

Articles (11)

Anti-CD26 Antibody Suppresses Epithelial-Mesenchymal Transition in Colorectal Cancer Stem Cells

An abnormal increase in CD26(−)CD28(−) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosus

Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease

Transcriptome Analysis of Fibroblasts in Hypoxia-Induced Vascular Remodeling: Functional Roles of CD26/DPP4

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies

Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease.

Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV

IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells

Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

Single-cell atlas of colonic CD8+ T cells in ulcerative colitis

Collaborators (12)

Tsutomu Sato

Yusuke Kamihara

Kotaro Honda

Takeshi Kawasaki

Daniele Corridoni

Hashem Koohy

Hiroyuki Kishi

Akinori Wada

Yuji Kamikubo

Yoshihiro Hayakawa

Yoshitoshi Kasuya

David Fawkner-Corbett

Make your next move.